Medical Director, US Rare Cardiac, non-MD

Role Responsibilities

• Support development and execution of U.S. medical strategies and tactics for Vyndamax.
• Collaborate cross-functionally (commercial, field medical, HEOR, digital, U.S. medical information) to enhance and deliver U.S. medical plans.
• Serve as a Medical Affairs reviewer in the U.S. Review Committee (RC) to ensure scientific accuracy and compliance of promotional and non‑promotional materials.
• Act as a scientific resource on ATTR-CM disease state, clinical data, product labeling, and competitive landscape.
• Support and coordinate U.S. medical congress activities (coverage planning, session prioritization, onsite support).
• Provide scientific input for medical/educational content ensuring accuracy, clinical relevance, and strategy alignment.
• Support customer insights and insight‑generation activities (e.g., advisory boards) with Field Medical and internal stakeholders.
• Deliver therapeutic area and product training to cross‑functional colleagues.
• Partner with U.S. Medical Information for expert input into Medical Letters and response documents.

• Doctoral degree in clinical/pharmacy (Ph.D./Pharm.D) with 5+ years;
  Master’s with 7+ years;
  Bachelor’s with 8+ years.
• Preferred:
  Heart Failure/ATTR-CM knowledge and experience.
• Understanding of drug development process; health care economics; strong analytical skills.
• Customer‑oriented, strategic thinking, deadline management, creativity/resourcefulness, strong communication/presentation skills.

Last date to apply:
July 13, 2026.

Work location:

NYHQ.

Relocation package:
No.

Annual base salary range: $176,600–$294,300; bonus target 20% of base; eligibility for long‑term incentives and comprehensive benefits (incl. 401(k)).